𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells

✍ Scribed by Arihiro Shibata; Takashi Nagaya; Tsuneo Imai; Hiroomi Funahashi; Akimasa Nakao; Hisao Seo

Book ID
110343122
Publisher
Springer US
Year
2002
Tongue
English
Weight
151 KB
Volume
73
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novobiocin decreases SMYD3 expression an
Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells
✍ Xue-Gang Luo; Jia-Ning Zou; Shu-Zhen Wang; Tong-Cun Zhang; Tao Xi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

## Abstract SET and MYND domain‐containing protein 3 (SMYD3) is a histone methyltransferase that plays an important role in transcriptional regulation in human carcinogenesis, and heat‐shock protein HSP90A has been shown to increase the activity of SMYD3. We previously reported that overexpression

Targeting the NF-κB pathway in estrogen
Targeting the NF-κB pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs
✍ Noel R. Monks; Arthur B. Pardee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Cancer cells in order to survive are often mutated to block apoptosis. One chemotherapeutic option is the re-establishment of apoptosis. An example of such a therapy is the PKC inhibitor Go ¨6976, which activates apoptosis and shrinks in vivo tumors in estrogen receptor-negative breast cancers. We p